Vipra Dhir

Title: Vipra Dhir: Innovator in Hemagglutination Assays

Introduction

Vipra Dhir is a notable inventor based in Orlando, FL (US). He has made significant contributions to the field of virology through his innovative approaches to hemagglutination assays. His work focuses on enhancing the sensitivity and efficiency of these critical assays, which are essential for analyzing virus-cell interactions.

Latest Patents

Vipra Dhir holds a patent for "Surface-assisted hemagglutination and hemagglutination inhibition assays." This invention addresses the limitations of traditional hemagglutination (HA) and hemagglutination inhibition (HAI) assays, which often require large volumes of viruses, erythrocytes, sera, and antibodies. The new method utilizes activated surfaces of specifically opsonized plates and ELISA plates to significantly improve sensitivity. This advancement allows for the characterization of functional antibodies in tested sera and fluids, a capability not possible with classical HAI assays. The methods can also enhance agglutination techniques using latex beads and target cells beyond erythrocytes.

Career Highlights

Vipra Dhir is associated with Sanofi Pasteur Vaxdesign Corporation, where he applies his expertise in virology and assay development. His innovative work has positioned him as a key figure in the advancement of viral analysis techniques.

Collaborations

He has collaborated with notable colleagues such as Anatoly Kachurin and Vaughan Wittman, contributing to the development of more effective virology assays.

Conclusion

Vipra Dhir's contributions to the field of hemagglutination assays represent a significant advancement in virology. His innovative approaches enhance the sensitivity and effectiveness of critical assays, paving the way for improved analysis of virus-cell interactions.